Search company, investor...

Compare Advanced Cell Diagnostics vs LineaGen Research

Customers evaluate the quality of Advanced Cell Diagnostics's products using the following success metrics.

Overview

Advanced Cell Diagnostics is based in United States

Advanced Cell Diagnostics (ACD) is a provider in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. The company's products and services are based on its proprietary RNAscope(TM) technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity. ACD partners with pharmaceutical and biotechnology companies to validate biomarkers for targeted therapeutic development in cancer and other diseases. These partnerships provide the foundation for ACD to develop companion diagnostic tests in conjunction with partners' targeted therapeutics. ACD also pursues internal programs to develop proprietary diagnostic tests in cancer management.

LineaGen Research is 22 yrs old and is based in United States.

Lineagen's mission is to accelerate and enhance the diagnostic evaluation of medical conditions so that the best possible outcomes can be achieved for patients and their families. The company's first commercial offering, FirstStepDx PLUS, provides physicians with a fully integrated genetic testing, counseling, and developmental screening service to aid in the diagnostic evaluation of individuals with ASD or other forms of developmental delay. In addition to its deep commitment to ASD and developmental delay, the company has ongoing scientific programs in the areas of multiple sclerosis (MS) and chronic obstructive pulmonary disease (COPD). On August 24th, 2020, LineaGen Research was acquired by Bionano Genomics.6M.

Country

United States

Demo Video

Demo not available because Advanced Cell Diagnostics has not claimed their profile.

Work for Advanced Cell Diagnostics? Show off your product.

Demo not available because LineaGen Research has not claimed their profile.

Work for LineaGen Research? Show off your product.

Leadership

Jessie Qian Wang (Chief Financial Officer)

See all 5 people

Stephen M. Prescott (Founder)

See all 5 people

Investors

Bio-Techne, Morningside Ventures

See all 5 investors

BioNano Genomics, Sanderling Ventures

See all 5 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Advanced Cell Diagnostics has not claimed their profile.

Work for Advanced Cell Diagnostics? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Advanced Cell Diagnostics?

Claim your profile now.

Information not available because LineaGen Research has not claimed their profile.

Work for LineaGen Research? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for LineaGen Research?

Claim your profile now.

Expert Collections

D

Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

M

Mental Health Tech

742 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.